Deltec Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $47.5K | Hold |
|
|||||
|
2024
Q3 | $39.9K | Hold |
|
|||||
|
2024
Q2 | $31.5K | Sell |
|
|||||
|
2024
Q1 | $115K | Sell |
|
|||||
|
2023
Q4 | $609K | Sell |
|
|||||
|
2023
Q3 | $586K | Sell |
|
|||||
|
2023
Q2 | $1.06M | Sell |
|
|||||
|
2023
Q1 | $1.01M | Buy |
|
|||||
|
2022
Q4 | $491K | Sell |
|
|||||
|
2022
Q3 | $839K | Buy |
|
|||||
|
2022
Q2 | $625K | Buy |
|
|||||
|
2022
Q1 | $635K | Sell |
|
|||||
|
2021
Q4 | $1.2M | Sell |
|
|||||
|
2021
Q3 | $1.13M | Buy |
|
|||||
|
2021
Q2 | $1.12M | Sell |
|
|||||
|
2021
Q1 | $2.67M | Sell |
|
|||||
|
2020
Q4 | $3.41M | Sell |
|
|||||
|
2020
Q3 | $5.06M | Buy |
|
|||||
|
2020
Q2 | $684K | Buy |
|